MITODAC

Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the treatment of degenerative brain disease